Maarten Ijzerman

Professor Maarten Ijzerman holds honorary professorships at the University of Melbourne's Melbourne School of Population and Global Health and the Centre for Health Policy, alongside his role as Dean of the Erasmus School of Health Policy and Management in the Netherlands. His expertise spans health economics, oncology care optimization, and health technology assessment, with a focus on genomic medicine implementation and equitable cancer treatment access. He leads major initiatives like the PRIMCAT project, analyzing cancer treatment economic impacts, and chairs the Rotterdam Global Health Initiative.

Research interests include precision oncology, dynamic simulation modeling for healthcare systems, and multi-criteria decision analysis for policy decisions. He has contributed to international HTA guidelines and led studies on biomarker-guided therapy, immunotherapy adverse event prediction, and multi-cancer screening efficiency. Active in translational research, he collaborates with institutions like the Victorian Comprehensive Cancer Centre and the Peter MacCallum Cancer Centre.

Key Projects:

• PRIMCAT: Predicting economic impact of cancer treatments
• System dynamics models for genomic sequencing implementation
• Clinical trials on pharmacogenetic dosing (PACIFIC-PGx)

Professional Roles: Chair of ISPOR’s Health Sciences Policy Council, non-executive board member across private/non-profit sectors, and former MSAC/PBAC committee member (Australia) and Dutch Pharmacoeconomic Guidelines Chair.

Research Impact: Over 300 publications focusing on health systems modeling, cost-effectiveness analysis, and translational health economics. Methodological contributions include frameworks for early HTA in AI radiology and structured expert elicitation protocols.